Literature DB >> 8116616

Understanding the mechanism(s) of mosaic trisomy 21 by using DNA polymorphism analysis.

C Pangalos1, D Avramopoulos, J L Blouin, O Raoul, M C deBlois, M Prieur, A A Schinzel, M Gika, D Abazis, S E Antonarakis.   

Abstract

In order to investigate the mechanism(s) underlying mosaicism for trisomy 21, we genotyped 17 families with mosaic trisomy 21 probands, using 28 PCR-detectable DNA polymorphic markers that map in the pericentromeric region and long arm of chromosome 21. The percentage of cells with trisomy 21 in the probands' blood lymphocytes was 6%-94%. There were two classes of autoradiographic results: In class I, a "third allele" of lower intensity was detected in the proband's DNA for at least two chromosome 21 markers. The interpretation of this result was that the proband had inherited three chromosomes 21 after meiotic nondisjunction (NDJ) (trisomy 21 zygote) and subsequently lost one because of mitotic (somatic) error, the lost chromosome 21 being that with the lowest-intensity polymorphic allele. The parental origin and the meiotic stage of NDJ could also be determined. In class II, a "third allele" was never detected. In these cases, the mosaicism probably occurred either by a postzygotic, mitotic error in a normal zygote that followed a normal meiosis (class IIA mechanism); by premeiotic, mitotic NDJ yielding an aneusomic zygote after meiosis, and subsequent mitotic loss (class IIB mechanism); or by a meiosis II error with lack of crossover in the preceding meiosis I, followed by mitotic loss after fertilization (class IIC mechanism). Among class II mechanisms, the most likely is mechanism IIA, while IIC is the least likely. There were 10 cases of class I and 7 cases of class II results.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8116616      PMCID: PMC1918141     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  21 in total

1.  Down syndrome: cytogenetical epidemiology.

Authors:  M Mikkelsen
Journal:  Hereditas       Date:  1977       Impact factor: 3.271

2.  Familial sex chromosomal mosaicism.

Authors:  R C Juberg; D J Holliday; V S Hennessy
Journal:  Am J Med Genet       Date:  1990-09

3.  Trisomy 21: association between reduced recombination and nondisjunction.

Authors:  S L Sherman; N Takaesu; S B Freeman; M Grantham; C Phillips; R D Blackston; P A Jacobs; A E Cockwell; V Freeman; I Uchida
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

4.  Use of short sequence repeat DNA polymorphisms after PCR amplification to detect the parental origin of the additional chromosome 21 in Down syndrome.

Authors:  M B Petersen; A A Schinzel; F Binkert; L Tranebjaerg; M Mikkelsen; F A Collins; E P Economou; S E Antonarakis
Journal:  Am J Hum Genet       Date:  1991-01       Impact factor: 11.025

5.  Origin of extra chromosome 21 in 343 families: cytogenetic and molecular approaches.

Authors:  F Dagna Bricarelli; M Pierluigi; M Grasso; P Strigini; L Perroni
Journal:  Am J Med Genet Suppl       Date:  1990

6.  Abundant class of human DNA polymorphisms which can be typed using the polymerase chain reaction.

Authors:  J L Weber; P E May
Journal:  Am J Hum Genet       Date:  1989-03       Impact factor: 11.025

7.  Maternal origin of a de novo balanced t(21q21q) identified by ets-2 polymorphism.

Authors:  N Créau-Goldberg; A Gegonne; J Delabar; C Cochet; M O Cabanis; D Stehelin; C Turleau; J de Grouchy
Journal:  Hum Genet       Date:  1987-08       Impact factor: 4.132

8.  The origin of mosaic Down syndrome: four cases with chromosome markers.

Authors:  N Niikawa; T Kajii
Journal:  Am J Hum Genet       Date:  1984-01       Impact factor: 11.025

9.  The meiotic stage of nondisjunction in trisomy 21: determination by using DNA polymorphisms.

Authors:  S E Antonarakis; M B Petersen; M G McInnis; P A Adelsberger; A A Schinzel; F Binkert; C Pangalos; O Raoul; S A Slaugenhaupt; M Hafez
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

10.  Parental origin of the extra chromosome in trisomy 21 as indicated by analysis of DNA polymorphisms. Down Syndrome Collaborative Group.

Authors:  S E Antonarakis
Journal:  N Engl J Med       Date:  1991-03-28       Impact factor: 91.245

View more
  19 in total

1.  Verb production by individuals with Down syndrome during narration.

Authors:  Susan J Loveall; Marie Moore Channell; Leonard Abbeduto; Frances A Conners
Journal:  Res Dev Disabil       Date:  2018-11-27

Review 2.  New approaches for modelling sporadic genetic disease in the mouse.

Authors:  Elizabeth M C Fisher; Eva Lana-Elola; Sheona D Watson; George Vassiliou; Victor L J Tybulewicz
Journal:  Dis Model Mech       Date:  2009 Sep-Oct       Impact factor: 5.758

3.  Maternal uniparental disomy 7 in Silver-Russell syndrome.

Authors:  M A Preece; S M Price; V Davies; L Clough; P Stanier; R C Trembath; G E Moore
Journal:  J Med Genet       Date:  1997-01       Impact factor: 6.318

4.  Molecular studies of the aetiology of trisomy 8 in spontaneous abortions and the liveborn population.

Authors:  R S James; P A Jacobs
Journal:  Hum Genet       Date:  1996-03       Impact factor: 4.132

5.  Klinefelter and trisomy X syndromes in patients with Prader-Willi syndrome and uniparental maternal disomy of chromosome 15--a coincidence?

Authors:  M G Butler; L K Hedges; P K Rogan; J R Seip; S B Cassidy; J B Moeschler
Journal:  Am J Med Genet       Date:  1997-10-03

Review 6.  Constitutional and acquired autosomal aneuploidy.

Authors:  Colleen Jackson-Cook
Journal:  Clin Lab Med       Date:  2011-12       Impact factor: 1.935

7.  Statistical models for trisomic phenotypes.

Authors:  N E Lamb; E Feingold; S L Sherman
Journal:  Am J Hum Genet       Date:  1996-01       Impact factor: 11.025

8.  Receptive vocabulary analysis in Down syndrome.

Authors:  Susan J Loveall; Marie Moore Channell; B Allyson Phillips; Leonard Abbeduto; Frances A Conners
Journal:  Res Dev Disabil       Date:  2016-04-13

9.  The phenotype of persons having mosaicism for trisomy 21/Down syndrome reflects the percentage of trisomic cells present in different tissues.

Authors:  Paulie Papavassiliou; Timothy P York; Nurcan Gursoy; Gloria Hill; Lauren Vanner Nicely; Usha Sundaram; Allison McClain; Steven H Aggen; Lindon Eaves; Brien Riley; Colleen Jackson-Cook
Journal:  Am J Med Genet A       Date:  2009-02-15       Impact factor: 2.802

10.  Cytogenetic and molecular studies of Down syndrome individuals with leukemia.

Authors:  J J Shen; B J Williams; A Zipursky; J Doyle; S L Sherman; P A Jacobs; A L Shugar; S W Soukup; T J Hassold
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.